COVID-3D: An online resource to explore the structural distribution of genetic variation in SARS-CoV-2 and its implication on therapeutic development
Portelli, S.; Olshansky, M.; Rodrigues, C. H. M.; D'Souza, E. N.; Myung, Y.; Silk, M.; Alavi, A.; Pires, D. E. V.; Ascher, D. B.
Show abstract
The emergence of the COVID-19 pandemic has spurred a global rush to uncover basic biological mechanisms, to inform effective vaccine and drug development. Despite viral novelty, global sequencing efforts have already identified genomic variation across isolates. To enable easy exploration and spatial visualization of the potential implications of SARS-CoV-2 mutations on infection, host immunity and drug development we have developed COVID-3D (http://biosig.unimelb.edu.au/covid3d/).
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Natural variants in SARS-CoV-2 S protein pinpoint structural and functional hotspots; implications for prophylaxis and therapeutics strategies 94%
- Using machine learning to detect coronaviruses potentially infectious to humans 93%
- Structural consequences of BMPR2 kinase domain mutations causing pulmonary arterial hypertension 92%
Similar papers in this journal
- Small-molecule modulators of TRMT2A decrease PolyQ aggregation and PolyQ-induced cell death 92%
- Towards mechanistic models of mutational effects: Deep Learning on Alzheimer's Aβ peptide 91%
- The Impact of Gag Non-Cleavage Site Mutations on HIV-1 Viral Fitness from Integrative Modelling and Simulations 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.